The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease

MJ Davies, CL Hawkins - Antioxidants & redox signaling, 2020 - liebertpub.com
Significance: The release of myeloperoxidase (MPO) by activated leukocytes is critical in
innate immune responses. MPO produces hypochlorous acid (HOCl) and other strong …

Ferroptosis: the potential value target in atherosclerosis

S Ouyang, J You, C Zhi, P Li, X Lin, X Tan, W Ma… - Cell Death & …, 2021 - nature.com
In advanced atherosclerosis (AS), defective function-induced cell death leads to the
formation of the characteristic necrotic core and vulnerable plaque. The forms and …

Dysfunctional HDL and atherosclerotic cardiovascular disease

RS Rosenson, HB Brewer Jr, BJ Ansell… - Nature reviews …, 2016 - nature.com
High-density lipoproteins (HDLs) protect against atherosclerosis by removing excess
cholesterol from macrophages through the ATP-binding cassette transporter A1 (ABCA1) …

Neutrophils in aging and aging‐related pathologies

K Van Avondt, JK Strecker, C Tulotta… - Immunological …, 2023 - Wiley Online Library
Over the past millennia, life expectancy has drastically increased. While a mere 25 years
during Bronze and Iron ages, life expectancy in many European countries and in Japan is …

[HTML][HTML] Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles

W Tong, H Hui, W Shang, Y Zhang, F Tian, Q Ma… - Theranostics, 2021 - ncbi.nlm.nih.gov
Inflammation is a pivotal driver of atherosclerotic plaque progression and rupture and is a
target for identifying vulnerable plaques. However, challenges arise with the current in vivo …

An abundant dysfunctional apolipoprotein A1 in human atheroma

Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li… - Nature medicine, 2014 - nature.com
Recent studies have indicated that high-density lipoproteins (HDLs) and their major
structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are …

Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies

C Silvestre-Roig, MP De Winther, C Weber… - Circulation …, 2014 - Am Heart Assoc
Understanding the pathophysiology of atherogenesis and the progression of atherosclerosis
have been major goals of cardiovascular research during the previous decades. However …

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture

N Teng, GJ Maghzal, J Talib, I Rashid, AK Lau… - Redox …, 2017 - Taylor & Francis
Atherosclerosis is the main pathophysiological process underlying coronary artery disease
(CAD). Acute complications of atherosclerosis, such as myocardial infarction, are caused by …

Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases

MJ Davies - Pharmacology & Therapeutics, 2021 - Elsevier
Heme peroxidases are a major source of reactive oxidants at sites of inflammation in
biological systems. The formation of some of these oxidants (eg hypochlorous acid, HOCl) is …

Inflammatory changes in the aneurysm wall: a review

R Tulamo, J Frösen, J Hernesniemi… - Journal of …, 2018 - jnis.bmj.com
Rupture of a saccular intracranial artery aneurysm (IA) causes subarachnoid hemorrhage, a
significant cause of stroke and death. The current treatment options, endovascular coiling …